Focal Electrically-Administered Seizure Therapy (FEAST) Studies at Two Enrolling Sites to Further Test and Refine the Treatment

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

June 10, 2019

Study Completion Date

June 10, 2019

Conditions
Depression
Interventions
DEVICE

FEAST

FEAST is a new form of ECT, with directional current, rather than traditional alternating current which goes in both directions between the electrodes.

DEVICE

RUL UB

This is right unilateral ultrabrief ECT, the standard of care.

Trial Locations (2)

29425

Medical University of South Carolina Brain Stimulation Division, Charleston

30912

Georgia Regents Medical Center, Augusta

All Listed Sponsors
collaborator

Augusta University

OTHER

lead

Medical University of South Carolina

OTHER

NCT02535572 - Focal Electrically-Administered Seizure Therapy (FEAST) Studies at Two Enrolling Sites to Further Test and Refine the Treatment | Biotech Hunter | Biotech Hunter